SCHEMBL7914511

SCHEMBL7914511

C[C@@H]1CC[C@H](O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30782476 1.00
SCHEMBL17061707 1.00
SCHEMBL2297929 1.00
SCHEMBL2924066 1.00
SCHEMBL2924068 1.00
SCHEMBL25040954 1.00
Hydrochloric Acid SCHEMBL14880473 0.97
Hydrochloric Acid SCHEMBL14880475 0.97
Hydrochloric Acid SCHEMBL16198457 0.97
Hydrochloric Acid SCHEMBL31404651 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4198017-A1 BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Academy of Military Medical Sciences (CN) 2023-06-21 EP disclosed
WO-2022111621-A1 AMINOHETEROARYL KINASE INHIBITORS ANRUI BIOMEDICAL TECHNOLOGY (GUANGZHOU) CO., LTD. (CN) 2022-06-02 WO disclosed
WO-2022033303-A1 BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 中国人民解放军军事科学院军事医学研究院 2022-02-17 WO disclosed
US-20180370973-A1 FUSED HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2018-12-27 US disclosed
US-10010539-B2 Pyrazole, triazole and tetrazole orexin receptor antagonists MERCK SHARP & DOHME CORP. (US) 2018-07-03 US disclosed
US-9988351-B2 Method for producing 5-hydroxypiperidine-2-carboxylic acid API CORPORATION (JP) 2018-06-05 US disclosed
US-20180002286-A1 METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID API CORPORATION (JP) 2018-01-04 US disclosed
US-20170319560-A1 PYRAZOLE, TRIAZOLE AND TETRAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2017-11-09 US disclosed
US-20170319560-A1 PYRAZOLE, TRIAZOLE AND TETRAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2017-11-09 US disclosed
US-9790181-B2 Method for producing 5-hydroxypiperidine-2-carboxylic acid API CORPORATION (JP) 2017-10-17 US disclosed
WO-2014137883-A1 2-PYRIDYLOXY-4-ETHER OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-09-12 WO disclosed
WO-2014099698-A1 2-PYRIDYLOXY-3-NITRILE-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-06-26 WO disclosed
WO-2014099698-A1 2-PYRIDYLOXY-3-NITRILE-4-SUBSTITUTED OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-06-26 WO disclosed
WO-2014066196-A1 2-PYRIDYLOXY-3-SUBSTITUTED-4-NITRILE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-05-01 WO disclosed
WO-2014066196-A1 2-PYRIDYLOXY-3-SUBSTITUTED-4-NITRILE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-05-01 WO disclosed
US-8710076-B2 2,5-disubstituted piperidine orexin receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-04-29 US disclosed
US-8710076-B2 2,5-disubstituted piperidine orexin receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-04-29 US disclosed
US-20110201632-A1 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists MERCK SHARP & DOHME LLC 2011-08-18 US disclosed
US-20110201632-A1 2,5-Disubstituted Piperidine Orexin Rceptor Antagonists MERCK SHARP & DOHME LLC 2011-08-18 US disclosed
WO-2010048012-A1 2,5-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-04-29 WO disclosed